Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
STXS
#3704
Stereotaxis, Inc. Common Stock
1.919
9
USD
-4.96%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-4.96%
Changement Mensuel
-0.51%
Evolution sur 6 mois
-7.70%
Changement Annuel
-7.70%
Clôture Précédente
2.020
0
Open
2.000
0
Bid
Ask
Low
1.850
0
High
2.000
0
Volume
46
Marchés
Actions des Marchés US
Soins de Santé
STXS
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
73.76 M
74.64 M
75.05 M
82.13 M
85.98 M
97.25 M
—
Valuation ratios
Enterprise value
333.66 M
424.02 M
149.02 M
133.76 M
183.82 M
210.25 M
815.97 M
Price to earnings ratio
-46.27
-38.75
-8.08
-6.93
-7.6
-9.2
-33.29
Price to sales ratio
13.87
13.38
5.58
5.42
7.03
6.37
26.44
Price to cash flow ratio
-105.44
-159.02
-18.98
-16.51
-22.86
-15.29
-89.16
Price to book ratio
10.7
13.85
6.06
9.23
31.94
15.52
45.41
Enterprise value to EBITDA ratio
-51.34
-33.62
-8.28
-6.55
-7.97
-10.47
-37.78
Profitability ratios
Return on assets %
-0.12
-0.18
-0.34
-0.49
-0.51
-0.41
-0.47
Return on equity %
-0.19
-0.32
-0.69
-1.27
-3.95
-1.61
-6.09
Return on invested capital %
-227.69
-373.1
-434.78
-508.83
-402.05
-263.14
—
Gross margin %
71.04
66.36
64.51
53.32
52.85
51.98
208.46
Operating margin %
-25.15
-36.81
-65.58
-78.37
-89.6
-67.32
-273.94
EBITDA margin %
-24.42
-36.54
-62.84
-73.33
-83.57
-61.17
-232.91
Net margin %
-24.9
-30.61
-63.89
-74.33
-87.08
-65.9
-268.27
Liquidity ratios
Quick ratio
3.64
3.54
2.47
1.88
0.84
1.09
3.15
Current ratio
3.88
3.87
3.03
2.51
1.22
1.51
4.95
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.54
0.6
0.5
0.58
0.62
0.66
0.72
Solvency ratios
Debt to assets ratio
0.04
0
—
—
—
—
—
Debt to equity ratio
0.06
0
—
—
—
—
—
Long term debt to total assets ratio
0.02
0
—
—
—
—
—
Long term debt to total equity ratio
0.03
0
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.05
-0.04
-0.11
-0.11
-0.1
-0.15
-0.15
EBIT per share
-0.09
-0.17
-0.24
-0.26
-0.28
-0.24
-0.24
EBITDA per share
-0.09
-0.17
-0.24
-0.25
-0.27
-0.22
-0.21
Total debt per share
0.03
0
—
—
—
—
—
Cash per share
0.6
0.51
0.37
0.25
0.14
0.15
0.46
Net current asset value per share
0.72
0.68
0.57
0.41
0.31
0.37
1.21
Tangible book value per share
0.48
0.45
0.35
0.2
-0.06
0.04
-0.21
Working capital per share
0.54
0.5
0.38
0.25
0.06
0.13
0.23
Book value per share
0.48
0.45
0.35
0.2
0.07
0.15
0.27
Nouvelles
Shield Therapeutics affiche une croissance de 56% et devient cash-flow positif
Citizens relève ses perspectives sur l’action Stereotaxis avec la montée en puissance des cathéters
Stereotaxis: Medical Robotics Upside Offsets Cash Burn And Execution Risks (NYSE:STXS)
Stereotaxis, Inc. (STXS) Q4 2025 Earnings Call Transcript
Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates
Le BPA de Stereotaxis égale les attentes, le CA en dessous des prévisions
Stereotaxis earnings matched, revenue fell short of estimates
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Beats Revenue Estimates
Can Digital Subscriptions Become ISRG's New Revenue Stream in 2026?
OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates
TransMedics (TMDX) Beats Q4 Earnings and Revenue Estimates
Beta Bionics, Inc. (BBNX) Reports Q4 Loss, Tops Revenue Estimates